NCT00541970 2018-08-17Partially Blind Study to Evaluate Immunogenicity & Safety of GSK Bio's HPV Vaccine 580299 in Healthy Women Aged 9-25 YrsGlaxoSmithKlinePhase 1 Completed961 enrolled 43 charts